Search Results - Wo, Serena W

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    A coiled-coil masking domain for selective activation of therapeutic antibodies

    A coiled-coil masking domain for selective activation of therapeutic antibodies by Trang, Vivian H., Zhang, Xinqun, Yumul, Roma C., Zeng, Weiping, Stone, Ivan J., Wo, Serena W., Dominguez, Melissa M., Cochran, Julia H., Simmons, Jessica K., Ryan, Maureen C., Lyon, Robert P., Senter, Peter D., Levengood, Matthew R.

    Published in Nature biotechnology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Nonfucosylation of an anti-TIGIT antibody enhances FcγR engagement, driving innate immune activation and antitumor activity

    Nonfucosylation of an anti-TIGIT antibody enhances FcγR engagement, driving innate immune activation and antitumor activity by Smith, Alyson J, Thurman, Robert E, Zeng, Weiping, Grogan, Bryan, Lucas, Sasha, Gutierrez, Guadalupe, Heiser, Ryan A, Wo, Serena W, Blackmarr, Amber, Peterson, Scott, Gardai, Shyra J

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Stable binding to phosphatidylserine-containing membranes requires conserved arginine residues in tandem C domains of blood coagulation factor VIII

    Stable binding to phosphatidylserine-containing membranes requires conserved arginine residues in tandem C domains of blood coagulation factor VIII by Peters, Shaun C, Childers, Kenneth C, Mitchell, Corbin E, Avery, Nathan G, Reese, Jr, Steven S, Mitchell, Cristopher, Wo, Serena W, Swanson, Christopher D, Brison, Caileen M, Spiegel, Jr, P Clint

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Reversible Chemical Modification of Antibody Effector Function Mitigates Unwanted Systemic Immune Activation

    Reversible Chemical Modification of Antibody Effector Function Mitigates Unwanted Systemic Immune Activation by Moquist, Philip N., Zhang, Xinqun, Leiske, Chris I., Eng-Duncan, Nicole M.-L., Zeng, Weiping, Bindman, Noah A., Wo, Serena W., Wong, Abbie, Henderson, Clark M., Crowder, Karalyne, Lyon, Robert, Doronina, Svetlana O., Senter, Peter D., Neff-LaFord, Haley D., Sussman, Django, Gardai, Shyra J., Levengood, Matthew R.

    Published in Bioconjugate chemistry
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  5. 5
    An in Vitro Assay Using Cultured Kupffer Cells Can Predict the Impact of Drug Conjugation on in Vivo Antibody Pharmacokinetics

    An in Vitro Assay Using Cultured Kupffer Cells Can Predict the Impact of Drug Conjugation on in Vivo Antibody Pharmacokinetics by Meyer, David W, Bou, Lauren B, Shum, Sara, Jonas, Mechthild, Anderson, Martha E, Hamilton, Joe Z, Hunter, Joshua H, Wo, Serena W, Wong, Abbie O, Okeley, Nicole M, Lyon, Robert P

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Abstract 2656: Reversible chemical modification of antibodies: A complementary approach to tuning FcγR binding that maintains anti-tumor activity while mitigating peripheral immune activation

    Abstract 2656: Reversible chemical modification of antibodies: A complementary approach to tuning FcγR binding that maintains anti-tumor activity while mitigating peripheral immune... by Moquist, Philip N., Leiske, Chris I., Bindman, Noah A., Zhang, Xinqun, Duncan, Nicole, Zeng, Weiping, Wo, Serena W., Wong, Abbie, Henderson, Clark M., Crowder, Karalyne, Neff-LaFord, Haley D., Sussman, Django, Gardai, Shyra J., Levengood, Matthew R.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: